Clene Inc.
CLNNNASDAQHealthcare● Active
$5.60
+$0.27(+5.09%)
Market Cap$57735444
P/E Ratio—
52W High$13.5
52W Low$3.25
Clene Inc. (CLNN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CLNN · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.31
Est. -$0.50 · +38.0%
Revenue
$0.00B
Est. $0.00B · -70.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
CLNN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.35
Rev. $8.07B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.35
Rev. Est.$8.07B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.37 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 14, 2026 | -$0.50 | -$0.31 | +38.0% | $0.00B | $0.00B | -70.4% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -$0.74 | -$0.88 | -18.9% | $0.00B | $0.00B | +196.2% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$0.60 | -$0.85 | -41.7% | $0.00B | $0.00B | -76.7% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.49 | -$0.78 | -59.2% | $0.00B | $0.00B | -51.0% |
| ▲ Q2 FY2025 | May 7, 2025 | -$1.10 | -$0.50 | +54.5% | $0.00B | $0.00B | +26.8% |
| ▼ Q1 FY2025 | Mar 24, 2025 | -$1.21 | -$1.67 | -38.0% | $0.00B | $0.00B | -30.0% |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$1.34 | -$1.22 | +9.0% | $0.00B | $0.00B | -44.2% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.37
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
-$0.31
EPS Est.
-$0.50
EPS Surpr.
+38.0%
Revenue
$0.00B
Q1 FY2026
Mar 12, 2026Miss
EPS Actual
-$0.88
EPS Est.
-$0.74
EPS Surpr.
-18.9%
Revenue
$0.00B
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$0.85
EPS Est.
-$0.60
EPS Surpr.
-41.7%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$0.78
EPS Est.
-$0.49
EPS Surpr.
-59.2%
Revenue
$0.00B
Q2 FY2025
May 7, 2025Beat
EPS Actual
-$0.50
EPS Est.
-$1.10
EPS Surpr.
+54.5%
Revenue
$0.00B
Q1 FY2025
Mar 24, 2025Miss
EPS Actual
-$1.67
EPS Est.
-$1.21
EPS Surpr.
-38.0%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
-$1.22
EPS Est.
-$1.34
EPS Surpr.
+9.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.25 | $-0.16 | $-0.07 | 1 |
| Q3 FY2028 | $-0.23 | $-0.14 | $-0.06 | 1 |
| Q2 FY2028 | $-0.21 | $-0.13 | $-0.06 | 1 |
| Q1 FY2028 | $-0.22 | $-0.14 | $-0.06 | 1 |
| Q4 FY2027 | $0.11 | $0.27 | $0.43 | 1 |
| Q3 FY2027 | $-0.08 | $-0.05 | $-0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +38.0% | $6.50 | $7.05 | +8.46% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -18.9% | $5.58 | $5.92 | +6.09% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -41.7% | $9.41 | $7.30 | -22.42% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -59.2% | $3.65 | $3.60 | -1.37% |
| ▲ Q2 FY2025 | May 7, 2025 | +54.5% | $2.85 | $2.55 | -10.53% |
| ▼ Q1 FY2025 | Mar 24, 2025 | -38.0% | $4.14 | $3.92 | -5.31% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +9.0% | $5.30 | $4.82 | -9.06% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +33.8% | $5.88 | $4.50 | -23.47% |
Q2 FY2026+8.46%
Report Date
May 14, 2026
EPS Beat/Miss
+38.0%
Price Before
$6.50
Price After
$7.05
Q1 FY2026+6.09%
Report Date
Mar 12, 2026
EPS Beat/Miss
-18.9%
Price Before
$5.58
Price After
$5.92
Q4 FY2025-22.42%
Report Date
Nov 13, 2025
EPS Beat/Miss
-41.7%
Price Before
$9.41
Price After
$7.30
Q3 FY2025-1.37%
Report Date
Aug 14, 2025
EPS Beat/Miss
-59.2%
Price Before
$3.65
Price After
$3.60
Q2 FY2025-10.53%
Report Date
May 7, 2025
EPS Beat/Miss
+54.5%
Price Before
$2.85
Price After
$2.55
Q1 FY2025-5.31%
Report Date
Mar 24, 2025
EPS Beat/Miss
-38.0%
Price Before
$4.14
Price After
$3.92
Q4 FY2024-9.06%
Report Date
Nov 13, 2024
EPS Beat/Miss
+9.0%
Price Before
$5.30
Price After
$4.82
Q3 FY2024-23.47%
Report Date
Aug 7, 2024
EPS Beat/Miss
+33.8%
Price Before
$5.88
Price After
$4.50
Avg Beat Reaction-8.65%
Avg Miss Reaction-5.75%
Beat Rate4 / 8 quarters
Largest Move-23.47% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CLNN ends December
Clene Inc. (CLNN) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.31 — beating the analyst consensus of $-0.50 by +38.0%. The next CLNN earnings date is expected around September 1, 2026.
Each quarter, investors track CLNN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CLNN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CLNN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CLNN earnings · 5 questionsClene Inc.'s next earnings report is expected around September 1, 2026. CLNN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CLNN historically reports after market close (AMC).
CLNN earnings datewhen is CLNN earningsCLNN next earnings datewhen does CLNN report earningsCLNN earnings calendar
▸ Source: FMP · Clene Inc. SEC filings · US GAAP · Clene Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026